Cita APA

Hsu, P., Huang, C., Wang, C., Kuo, S. C., Chu, C., Tung, P., . . . Yang, C. (2020). The Combination of Afatinib and Bevacizumab in Untreated EGFR-Mutated Advanced Lung Adenocarcinoma: A Multicenter Observational Study. Pharmaceuticals (Basel).

Chicago Style Citation

Hsu, Ping-Chih, et al. "The Combination of Afatinib and Bevacizumab in Untreated EGFR-Mutated Advanced Lung Adenocarcinoma: A Multicenter Observational Study." Pharmaceuticals (Basel) 2020.

Cita MLA

Hsu, Ping-Chih, et al. "The Combination of Afatinib and Bevacizumab in Untreated EGFR-Mutated Advanced Lung Adenocarcinoma: A Multicenter Observational Study." Pharmaceuticals (Basel) 2020.